2024-12-21 2024-12-21 , online online, 1,330 € zzgl. MwSt. Dr. Christopher Brückner https://forum-institut.de/seminar/25051130-spc-update/referenten/25/25_05/25051130-course-supplementary-protection-certificates,-spcand-management_brueckner-christopher.jpg SPC Update

Our speaker, one of the leading SPC experts in Europe, will discuss the SPC referrals to the ECJ with you. He will put the decisions in context and will show you the consequences for national court practice and for your application practice.

The contents of your online course
  • Key issues of the Supplementary Protection Certificates
  • SPC reform, e.g. unitary SPC
  • ECJ referrals from Medeva to Genmab: context, background and interpretation
  • Impact of the referrals on application practice and national court practice
  • Pending referrals: what to expect from Teva v MSD (C-119/22)


Who should attend
Do you work in a corporate patent or IP department, or as a patent attorney in private practice and need an update on the ECJ's SPC case-law?

Then, this FORUM!Live online course is intended for you. Prior knowledge of patents is a requisite.
The objectives of your online course
In order to understand how to deal with supplementary protection certificates, one needs not only to understand the regulations but also the respective case-law. Thus the European Court of Justice has issued many important SPC decisions in the last few years: Medeva, Neurim, Actavis. The latest ones have raised more questions than have given answers. Our speaker, one of the leading SPC experts in Europe, will discuss the referrals with you. He will put the decisions in context and will show you the consequences for national court practice and for your application practice. Dr Brückner will also give some hints as to pending referrals and yet unsolved questions which might be the subject of future referrals. As 2024 might see a wide-reaching reform of the SPC law with, among others, a unitary SPC, our speaker will give you an overview and will explain to you what changes can be expected.
Your benefit

  • You will be up to date with the case-law of the European Court of Justice on supplementary protection certificates
  • You will get a better understanding of the articles of the regulations
  • You will understand the impact of the unitary patent and the Unified Patent Court on supplementary protection certificates
  • You will be up to date with regards to the EU SPC Reform

Course - Supplementary Protection Certificates, SPC and the ECJ

SPC Update

EU Reform And Case-Law

Benefits
  • Latest developments in brief
  • Optional booking: pre-course
  • Participants will receive a copy of the 3rd edition of the SPC commentary - registration
made by 29 February

Webcode 25051130

Jetzt buchen

JETZT Buchen
Referent

Dr. Christopher Brückner

Patent Attorney/Pharmacist, Dennemeyer & Associates, Munich (Germany)

Dr Christopher Brückner is a German and European Patent Attorney and Pharmacist with Dennemeyer & Associates based in Munich, Germany. He is the author of the standard reference commentary on SPC law. In addition he is coauthor of the EPC commentary Singer/Stauder. He is a sought-after author, lecturer (Supplementary Protection Certificates, SPC for Beginners) and commentator in this field. In 2012, the Düsseldorf Higher Regional Court appointed Christopher as an independent legal expert in a patent dispute in the pharmaceutical field. In 2016, the Max Planck Institute for Innovation and Competition requested that Dr Brückner participates in the preparation of a study commissioned by the EU. The purpose of the study is to determine whether the current EU Regulation 469/2009 for SPCs meets today's technical and legal requirements.

Alles auf einen Blick

Termin

14-15/05/2025

14-15/05/2025

Zeitraum

Pre-course: starts at 13:00 CET, ends at 17:15 CET I Advanced course: starts at 09:00 CET, ends at 17:00 CET

Pre-course: starts at 13:00 CET, ends at 17:15 CET I Advanced course: starts at 09:00 CET, ends at 17:00 CET
Veranstaltungsort

online

online

Downloads
White paper: IP strategy - where to start White paper on generative AI in patents
White paper: IP strategy - where to start White paper on generative AI in patents
Gebühr

Veranstaltung - 1,330 € zzgl. MwSt.
The fee includes the 'live' participation via Internet, speaker's book, the access to the learning platform as well as course documentation for download. € 390 (+ German VAT) - pre-course (optional booking)
€ 1,330 (+ German VAT) - advanced course



OPTIONS
Pre-Course: Introduction to SPC
+390,00 €

Veranstaltung - 1,330 € zzgl. MwSt.
The fee includes the 'live' participation via Internet, speaker's book, the access to the learning platform as well as course documentation for download. € 390 (+ German VAT) - pre-course (optional booking)
€ 1,330 (+ German VAT) - advanced course


OPTIONS
Pre-Course: Introduction to SPC
+390,00 €

Inhouse-Angebote
Inhouse-Angebot anfordern
Inhouse-Angebot anfordern

Jetzt buchen

Your contact

Jean-Claude Alexandre Ho, LL.M.
Lawyer, Conference Manager

+49 6221 500-675
jc.alexandreho@forum-institut.de

Details

Our speaker, one of the leading SPC experts in Europe, will discuss the SPC referrals to the ECJ with you. He will put the decisions in context and will show you the consequences for national court practice and for your application practice.

The contents of your online course

  • Key issues of the Supplementary Protection Certificates
  • SPC reform, e.g. unitary SPC
  • ECJ referrals from Medeva to Genmab: context, background and interpretation
  • Impact of the referrals on application practice and national court practice
  • Pending referrals: what to expect from Teva v MSD (C-119/22)


Who should attend
Do you work in a corporate patent or IP department, or as a patent attorney in private practice and need an update on the ECJ's SPC case-law?

Then, this FORUM!Live online course is intended for you. Prior knowledge of patents is a requisite.

The objectives of your online course

In order to understand how to deal with supplementary protection certificates, one needs not only to understand the regulations but also the respective case-law. Thus the European Court of Justice has issued many important SPC decisions in the last few years: Medeva, Neurim, Actavis. The latest ones have raised more questions than have given answers. Our speaker, one of the leading SPC experts in Europe, will discuss the referrals with you. He will put the decisions in context and will show you the consequences for national court practice and for your application practice. Dr Brückner will also give some hints as to pending referrals and yet unsolved questions which might be the subject of future referrals. As 2024 might see a wide-reaching reform of the SPC law with, among others, a unitary SPC, our speaker will give you an overview and will explain to you what changes can be expected.

Your benefit

  • You will be up to date with the case-law of the European Court of Justice on supplementary protection certificates
  • You will get a better understanding of the articles of the regulations
  • You will understand the impact of the unitary patent and the Unified Patent Court on supplementary protection certificates
  • You will be up to date with regards to the EU SPC Reform

Detailed programme

Pre-course: starts at 13:00 CET, ends at 17:15 CET I Advanced course: starts at 09:00 CET, ends at 17:00 CET

Introduction to the basic terms
  • Structure of the EU SPC Regulation for Medicinal Products
  • Product - relevant deadlines - basic patent - relevant marketing authorization

Fundamental practical questions
  • What can be protected?
  • Application for a certificate based on third parties' authorisation
  • Date of grant of the basic patent and the marketing authorization

SPC key issues and SPC reform (Unitary SPC etc.)

Medeva, Eli Lilly, Actavis and Georgetown II referrals: laying the ground


From Merck vs Sigma to Genmab
  • Merck v Sigma (C-579/13), Pfizer Ireland (C-681/16): referrals on Specific Mechanism
  • Synflorix (C-631/13): definition of adjuvant
  • Boehringer (C-577/13): combination claimed in second patent
  • Forsgren (C-631/13): covalent binding of a biologic product
  • Seattle Genetics (C-471/14): date of market authorisation
  • F. Hoffmann - La Roche (C-572/15): duration of an SPC issued under national law
  • Incyte (C-492/16): date of expiry of an SPC
  • MSD (C-567/16): end of procedure notice equivalent to market authorisation?
  • Teva v Gilead (C-121/17): product protected by a basic patent in force
  • Boston Scientific (C-527/17): no SPCs for CE-marked devices
  • Abraxis (C-443/17): first marketing authorisation for new formulations
  • QH/Royalty Pharma (C 650/17): individualized embodiment
  • Santen v INPI (C-673/18): no SPC for new therapeutic applications
  • Mylan (C-473/22): liability for enforcing a later invalid patent
  • Genmab (C-181/24): second marketing authorisation

Pending referrals*: what to expect
  • Teva v MSD (C-119/22): "product" in Art 3(a) and Art 3(c)
*Further referrals will be covered if they are pending by the day of the course.

More informations

Agenda

The agenda hast been adapted speifically to the medium and the respective seminar.

It is as follows:

Pre-course: Introduction to SPC
15 May 2024 I Online
starts at 13:00 CET, ends at 17:15 CET
breaks at 14:15 and 15:45 CET

Advanced course: SPC Update
16 May 2024 I Online
starts at 09:00 CET, ends at 17:00 CET
breaks at 10:30, 12:15 and 15:30 CET

BONUS

Each participant will receive a copy of the 3rd edition of the SPC commentary by Dr. Brückner, the standard reference, if registration is made by 29 February 2024.

Introduction to SPC

Attendees without prior SPC knowledge/ education are advised to attend the introduction to SPC pre-course on 15 May 2024.

On the details of the programme

Please note that the details of the programme are so far preliminary and still subject to minor changes.

This distinguishes our events

Very informative and thought-provoking.

Very informative and thought-provoking.

Recommendations

Open Source Software: Licenses and Patents

Developers and their superiors need precise knowledge of the open source software (OSS) conditions of use to be complied...

20.02.2025, Online
Details

European Patent Opposition Advocacy Workshop

The European Patent Opposition Advocacy Workshop is the gold standard advocacy course where attendees will get hands-on ...

19. - 20.05.2025 in München
Details

Mastering Patent Portfolio Management in The Age of AI

Learn how to manage a patent portfolio with insights from a seasoned patent portfolio manager, with AI insights from AI ...

26.06.2025, Online
Details

Digital Patents: Claim Drafting

Learn how to write digital patent applications which get granted and are infringed upon! This online course will give yo...

27.05.2025, Online
Details

Amsterdam Masterclass: EPO Oppositions & Appeals

This masterclass will provide you with an intensive and practical overview of all relevant legal and practical issues co...

26. - 27.06.2025 in Amsterdam
Details

Go forward

White paper: Inside the Patent Factory

Download this whitepaper and get insights on the patent creation process.

Details
White paper: Inside the Patent Factory
White paper on generative AI in patents

Discover the future of patent work in the age of artificial intelligence in this expert interview with Sebastian Goebel.

Details
White paper:
White paper: IP strategy - where to start

Download this whitepaper with the views of ~400 IP professionals.

Details
White paper: IP strategy

Testimonials

Testimonial
'This is really helpful for building our IP department. What I liked most: the practical applicability of the course content. Excellent course for portfolio managers.'

Jan-Willem Louwaard, IP Senior Manager

Tenaris Connections


'The course has met my expectations. I liked that the course was practical.'

Jean-Christophe Raboin, European Patent Attorney

Total


'Good insight in portfolio management, practical tools, templates.'

European Patent Attorney